Published in Ann Allergy Asthma Immunol on May 01, 1997
Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax (2003) 1.47
Mechanisms and clinical implications of glucocorticosteroids in the treatment of allergic rhinitis. Clin Exp Immunol (2009) 0.89
Increase in histamine content and enhancement of high affinity IgE receptor FcepsilonRI expression in the human leukemia KU812 cells upon treatment with hydrocortisone. Cytotechnology (2000) 0.79
Intracellular delivery of nanoparticles of an antiasthmatic drug. AAPS PharmSciTech (2008) 0.79
Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol (1975) 10.52
Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am Rev Respir Dis (1993) 1.73
Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects. J Allergy Clin Immunol (1975) 1.68
Characterization of a murine model of allergic pulmonary inflammation. Int Arch Allergy Immunol (1994) 1.66
Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine. Clin Exp Allergy (2001) 1.63
Genetic analysis of allergic disease in twins. J Allergy Clin Immunol (1984) 1.46
Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med (1995) 1.40
The presence of airway reactivity before the development of asthma. Am Rev Respir Dis (1990) 1.32
Mast cells modulate allergic pulmonary eosinophilia in mice. Am J Respir Cell Mol Biol (1995) 1.32
Antitussive effects of GABAB agonists in the cat and guinea-pig. Br J Pharmacol (1993) 1.22
Cardiotoxic and drug interaction profile of the second generation antihistamines ebastine and terfenadine in an experimental animal model of torsade de pointes. Arzneimittelforschung (1996) 1.22
Obstructive lung disease in hereditary alpha 1-antitrypsin deficiency. JAMA (1970) 1.19
Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody. Am J Respir Cell Mol Biol (1995) 1.18
Effect of anti-mIL-9 antibody on the development of pulmonary inflammation and airway hyperresponsiveness in allergic mice. Am J Respir Cell Mol Biol (2001) 1.16
A membrane cofactor protein transgenic mouse model for the study of discordant xenograft rejection. Genes Cells (1996) 1.16
Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron. Blood (1997) 1.14
Difference between lung and spleen susceptibility of beta-adrenergic receptors to desensitization by terbutaline. J Allergy Clin Immunol (1983) 1.14
Dependence on insulin of the apparent hydrocortisone activation of hepatic glycogen synthetase. Proc Natl Acad Sci U S A (1967) 1.12
Peripheral and central sites of action of GABA-B agonists to inhibit the cough reflex in the cat and guinea pig. Br J Pharmacol (1994) 1.11
Segregation analysis of bronchial response to methacholine inhalation challenge in families with and without asthma. J Allergy Clin Immunol (1986) 1.11
Prejunctional GABA-B inhibition of cholinergic, neurally-mediated airway contractions in guinea-pigs. Pulm Pharmacol (1991) 1.10
The effect of age on methacholine response. J Allergy Clin Immunol (1985) 1.09
Effect of hydrocortisone on beta-adrenergic receptors in lung membranes. Life Sci (1979) 1.08
Retracted Effects of platelet activating factor on cyclic AMP accumulation in human lymphocytes. Ann Allergy (1992) 1.07
Notice of retraction. Effects of platelet activating factor on cyclic AMP accumulation in human lymphocytes. Ann Allergy (1992) 1.07
Interpretation of the results of methacholine inhalation challenge tests. J Allergy Clin Immunol (1987) 1.06
Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. J Allergy Clin Immunol (1998) 1.06
Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects. Arzneimittelforschung (1996) 1.06
Mycobacterial antigens attenuate late phase response, airway hyperresponsiveness, and bronchoalveolar lavage eosinophilia in a mouse model of bronchial asthma. Int Immunopharmacol (2001) 1.05
Role of nitric oxide on eosinophilic lung inflammation in allergic mice. Am J Respir Cell Mol Biol (1997) 1.04
Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung. Am Rev Respir Dis (1992) 1.03
Comparison of respiratory and cardiovascular effects of isoproterenol, propranolol, and practolol in asthmatic and normal subjects. J Allergy Clin Immunol (1976) 1.03
Duration and specificity of sodium cromolyn on allergen inhalation challenges in asthmatics. J Allergy Clin Immunol (1974) 1.03
Effect of terfenadine on the bronchoconstriction induced by ultrasonically nebulized distilled water. Ann Allergy (1988) 1.02
Methacholine inhalation challenge studies in a selected pediatric population. Am Rev Respir Dis (1986) 1.02
A set of ninety-seven overlapping yeast artificial chromosome clones spanning the human Y chromosome euchromatin. Genomics (1994) 1.02
C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study. Allergy (2011) 1.00
Measurement of exhaled nitric oxide by three different techniques. Am J Respir Crit Care Med (1996) 1.00
Effect of Sch 55700, a humanized monoclonal antibody to human interleukin-5, on eosinophilic responses and bronchial hyperreactivity. Arzneimittelforschung (1999) 0.97
Effects of chronic anti-interleukin-5 monoclonal antibody treatment in a murine model of pulmonary inflammation. Am J Respir Cell Mol Biol (1999) 0.97
Runx2 overexpression enhances osteoblastic differentiation and mineralization in adipose--derived stem cells in vitro and in vivo. Calcif Tissue Int (2006) 0.96
Pharmacological characterization of effects of nifedipine on isolated guinea-pig and rat tracheal smooth muscle. Arch Int Pharmacodyn Ther (1983) 0.95
Bronchial reactivity to histamine before and after sodium cromoglycate in bronchial asthma. Br Med J (1976) 0.94
[3H]leukotriene B4 binding to the guinea-pig spleen membrane preparation: a rich tissue source for a high-affinity leukotriene B4 receptor site. J Pharmacol Exp Ther (1986) 0.94
The effect of beta adrenergic blockade on bronchial sensitivity to acetyl-beta-methacholine in normal and allergic rhinitis subjects. J Allergy Clin Immunol (1976) 0.94
Activation of the STAT1 signalling pathway in lupus nephritis in MRL/lpr mice. Lupus (2007) 0.93
Methacholine inhalation challenge studies. J Allergy Clin Immunol (1979) 0.93
Measurement of bronchoconstriction using whole-body plethysmograph: comparison of freely moving versus restrained guinea pigs. J Pharmacol Toxicol Methods (1998) 0.93
Bronchial reactivity pattern in nonasthmatic parents of asthmatics. Ann Allergy (1988) 0.92
Inhibition of pulmonary eosinophilia and airway hyperresponsiveness in allergic mice by rolipram: involvement of endogenously released corticosterone and catecholamines. Br J Pharmacol (2000) 0.91
Protective effect opf lodoxamide tromethamine on allergen inhalation challenge. J Allergy Clin Immunol (1980) 0.91
Endogenous nitric oxide in allergic airway disease. J Allergy Clin Immunol (2000) 0.91
Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine. Agents Actions (1984) 0.90
Anaphylactic challenge causes eosinophil accumulation in bronchoalveolar lavage fluid of guinea pigs. Modulation by betamethasone, phenidone, indomethacin, WEB 2086, and a novel antiallergy agent, SCH 37224. Am Rev Respir Dis (1990) 0.90
Sensitization to anaphylaxis and to some of its pharmacological mediators by blockade of the beta adrenergic receptors. J Allergy (1967) 0.89
The pharmacology of SCH 50911: a novel, orally-active GABA-beta receptor antagonist. J Pharmacol Exp Ther (1995) 0.89
Eosinophils retain their granule major basic protein in a murine model of allergic pulmonary inflammation. Am J Respir Cell Mol Biol (1998) 0.89
A novel pyrrolidine analog of histamine as a potent, highly selective histamine H3 receptor agonist. J Med Chem (1995) 0.88
Effect of platelet-activating factor on beta-adrenoceptors in human lung. Biochem Biophys Res Commun (1987) 0.87
Resistance of gluconeogenic and glycogenic pathways in obese-hyperglycemic mice. Am J Physiol (1975) 0.86
(R)-alpha-methylhistamine augments neural, cholinergic bronchospasm in guinea pigs by histamine H1 receptor activation. Eur J Pharmacol (1992) 0.86
Comparison of PDE 4 inhibitors, rolipram and SB 207499 (ariflo), in a rat model of pulmonary neutrophilia. Pulm Pharmacol Ther (2001) 0.86
Inhibition of sympathetic hypertensive responses in the guinea-pig by prejunctional histamine H3-receptors. Br J Pharmacol (1992) 0.86
A novel class of platelet activating factor antagonists from Phoma sp. J Antibiot (Tokyo) (1993) 0.86
Mechanisms of allergic pulmonary eosinophilia in the mouse. J Allergy Clin Immunol (1994) 0.86
Effect of the PAF antagonists, CV-3988 and L-652,731 on the pulmonary and hematological responses to guinea pig anaphylaxis. Pharmacol Res Commun (1988) 0.86
In vitro and in vivo induction of bone formation based on ex vivo gene therapy using rat adipose-derived adult stem cells expressing BMP-7. Cytotherapy (2005) 0.86
5-HT3 receptors augment neuronal, cholinergic contractions in guinea pig trachea. Eur J Pharmacol (1993) 0.85
Calcium channel antagonists in coronary artery spasm and bronchial spasm. What do variant angina and bronchial asthma have in common? Chest (1982) 0.85
A group comparative study of the safety and efficacy of nedocromil sodium (Tilade) in reversible airways disease: a preliminary report. Eur J Respir Dis Suppl (1986) 0.84
Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects. Biochem Biophys Res Commun (1987) 0.84
Histamine H2-receptors in guinea pig peripheral airway smooth muscle. Life Sci (1979) 0.84
Phosphodiesterase inhibitors suppress proliferation of peripheral blood mononuclear cells and interleukin-4 and -5 secretion by human T-helper type 2 cells. Immunopharmacology (1996) 0.84
The effect of ketotifen on eosinophils as measured at LTC4 release and by chemotaxis. Allergy Proc (1991) 0.84
In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids. Arzneimittelforschung (1998) 0.84
Modification of eosinophil function by suplatast tosilate (IPD), a novel anti-allergic drug. Int Immunopharmacol (2001) 0.84
Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation. J Immunol (1988) 0.84
NK(2)-receptor mediated contraction in monkey, guinea-pig and human airway smooth muscle. Neuropeptides (1999) 0.83
Combined histamine H1 and H3 receptor blockade produces nasal decongestion in an experimental model of nasal congestion. Am J Rhinol (1999) 0.83
Tissue distribution and functional correlation of [3H]leukotriene C4 and [3H]leukotriene D4 binding sites in guinea-pig uterus and lung preparations. J Pharmacol Exp Ther (1985) 0.83
Inhibition of experimental acute pulmonary inflammation by pirfenidone. Pulm Pharmacol Ther (2003) 0.83
Serum ferritin: does it differ from tissue ferritin? J Gastroenterol Hepatol (1996) 0.83
Further evidence for prejunctional GABA-B inhibition of cholinergic and peptidergic bronchoconstriction in guinea pigs: studies with new agonists and antagonists. Pharmacology (1993) 0.82
Lymphocyte glucocorticoid receptors in asthmatic and control subjects. Clin Allergy (1984) 0.82
Distribution of methacholine inhalation challenge responses in a selected adult population. J Allergy Clin Immunol (1987) 0.82
Cromolyn therapy in patients with bronchial asthma. Effect on inhalation challenge with allergen, histamine, and methacholine. JAMA (1976) 0.82
Determination of serum aluminium using an ion-pair reversed-phase high-performance liquid chromatographic-fluorimetric system with lumogallion. J Chromatogr B Biomed Appl (1995) 0.81
The mechanism of corticosteroids in treating asthma. Ann Allergy (1987) 0.81
Safety of nifedipine in subjects with bronchial asthma and COPD. Chest (1984) 0.81